336 related articles for article (PubMed ID: 26333366)
1. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.
Hamshere S; Arnous S; Choudhury T; Choudry F; Mozid A; Yeo C; Barrett C; Saunders N; Gulati A; Knight C; Locca D; Davies C; Cowie MR; Prasad S; Parmar M; Agrawal S; Jones D; Martin J; McKenna W; Mathur A
Eur Heart J; 2015 Nov; 36(44):3061-9. PubMed ID: 26333366
[TBL] [Abstract][Full Text] [Related]
2. An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial.
Choudhury T; Mozid A; Hamshere S; Yeo C; Pellaton C; Arnous S; Saunders N; Brookman P; Jain A; Locca D; Archbold A; Knight C; Wragg A; Davies C; Mills P; Parmar M; Rothman M; Choudry F; Jones DA; Agrawal S; Martin J; Mathur A
Eur J Heart Fail; 2017 Jan; 19(1):138-147. PubMed ID: 27790824
[TBL] [Abstract][Full Text] [Related]
3. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
[TBL] [Abstract][Full Text] [Related]
4. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study).
Martino H; Brofman P; Greco O; Bueno R; Bodanese L; Clausell N; Maldonado JA; Mill J; Braile D; Moraes J; Silva S; Bozza A; Santos B; Campos de Carvalho A;
Eur Heart J; 2015 Nov; 36(42):2898-904. PubMed ID: 26392433
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mononuclear cell therapy for nonischaemic dilated cardiomyopathy-A meta-analysis.
Wen Y; Ding J; Zhang B; Gao Q
Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29359515
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†.
Choudry F; Hamshere S; Saunders N; Veerapen J; Bavnbek K; Knight C; Pellerin D; Locca D; Westwood M; Rakhit R; Crake T; Kastrup J; Parmar M; Agrawal S; Jones D; Martin J; Mathur A
Eur Heart J; 2016 Jan; 37(3):256-63. PubMed ID: 26405233
[TBL] [Abstract][Full Text] [Related]
7. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
[TBL] [Abstract][Full Text] [Related]
8. The Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGENERATE-DCM) trial: study design.
Arnous S; Mozid A; Mathur A
Regen Med; 2011 Jul; 6(4):525-33. PubMed ID: 21749209
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Comparative Study on the Efficacy of Intracoronary Infusion of Autologous Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells in Patients With Dilated Cardiomyopathy.
Xiao W; Guo S; Gao C; Dai G; Gao Y; Li M; Wang X; Hu D
Int Heart J; 2017 Apr; 58(2):238-244. PubMed ID: 28190794
[TBL] [Abstract][Full Text] [Related]
10. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.
Assmus B; Walter DH; Seeger FH; Leistner DM; Steiner J; Ziegler I; Lutz A; Khaled W; Klotsche J; Tonn T; Dimmeler S; Zeiher AM
JAMA; 2013 Apr; 309(15):1622-31. PubMed ID: 23592107
[TBL] [Abstract][Full Text] [Related]
11. Immunologic Network and Response to Intramyocardial CD34+ Stem Cell Therapy in Patients With Dilated Cardiomyopathy.
Haddad F; Sever M; Poglajen G; Lezaic L; Yang P; Maecker H; Davis M; Kuznetsova T; Wu JC; Vrtovec B
J Card Fail; 2015 Jul; 21(7):572-82. PubMed ID: 25863169
[TBL] [Abstract][Full Text] [Related]
12. DCM Support: cell therapy and circulatory support for dilated cardiomyopathy patients with severe ventricular impairment.
Reid A; Hussain M; Veerapen J; Ramaseshan R; Hall R; Bowles R; Jones DA; Mathur A
ESC Heart Fail; 2023 Aug; 10(4):2664-2671. PubMed ID: 37190883
[TBL] [Abstract][Full Text] [Related]
13. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
[TBL] [Abstract][Full Text] [Related]
14. A randomized study of autologous bone marrow-derived stem cells in pediatric cardiomyopathy.
Pincott ES; Ridout D; Brocklesby M; McEwan A; Muthurangu V; Burch M
J Heart Lung Transplant; 2017 Aug; 36(8):837-844. PubMed ID: 28162930
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI. A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial.
San Roman JA; Sánchez PL; Villa A; Sanz-Ruiz R; Fernandez-Santos ME; Gimeno F; Ramos B; Arnold R; Serrador A; Gutiérrez H; Martin-Herrero F; Rollán MJ; Fernández-Vázquez F; López-Messa J; Ancillo P; Pérez-Ojeda G; Fernández-Avilés F
J Am Coll Cardiol; 2015 Jun; 65(22):2372-82. PubMed ID: 26046730
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy.
Lu Y; Wang Y; Lin M; Zhou J; Wang Z; Jiang M; He B
Stem Cell Res Ther; 2016 Dec; 7(1):186. PubMed ID: 27938412
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
Ripa RS
Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
[TBL] [Abstract][Full Text] [Related]
19. Effects of Repetitive Transendocardial CD34
Vrtovec B; Poglajen G; Sever M; Zemljic G; Frljak S; Cerar A; Cukjati M; Jaklic M; Cernelc P; Haddad F; Wu JC
Circ Res; 2018 Jul; 123(3):389-396. PubMed ID: 29880546
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure.
Bocchi EA; Bacal F; Guimarães G; Mendroni A; Mocelin A; Filho AE; Dores da Cruz Fd; Resende MC; Chamone D
Int J Cardiol; 2010 Jan; 138(1):94-7. PubMed ID: 18675477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
